We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Funding orphan medicinal products beyond price: sustaining an ecosystem.
- Authors
de Sola-Morales, Oriol
- Abstract
The article offers information on the need of the orphan medicinal products legislation in the U.S. It discusses the policy and political implications of funding the therapies in the advent of increasing personalized medicine. It mentions the laws for the regulation of the drug prices in the U.S. along with analysis of the EBITDA of a sample of orphan medicinal products dedicated companies.
- Subjects
UNITED States; ORPHAN drugs; INDIVIDUALIZED medicine; DRUG laws; DRUG prices; EBITDA (Accounting)
- Publication
European Journal of Health Economics, 2019, Vol 20, Issue 9, p1283
- ISSN
1618-7598
- Publication type
editorial
- DOI
10.1007/s10198-019-01047-0